Electromed Stock Performance
| ELMD Stock | USD 30.26 0.47 1.58% |
Electromed holds a performance score of 30 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.04, which means a somewhat significant risk relative to the market. Electromed returns are very sensitive to returns on the market. As the market goes up or down, Electromed is expected to follow. Use Electromed maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to analyze future returns on Electromed.
Risk-Adjusted Performance
30 of 100
Weak | Strong |
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Electromed are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Electromed exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.4 | Five Day Return 4.76 | Year To Date Return 182.34 | Ten Year Return 1.2 K | All Time Return 663.32 |
1 | Acquisition by James Cunniff of 15900 shares of Electromed subject to Rule 16b-3 | 09/03/2024 |
2 | Electromed Inc Trading 3.1 percent Higher on Sep 17 | 09/17/2024 |
3 | Electromed stock soars to all-time high of 20.83 - Investing.com | 09/27/2024 |
4 | Electromed Inc Trading 3.92 percent Higher on Oct 2 | 10/02/2024 |
5 | Electromed, Inc. Schedules its First Quarter Fiscal 2025 Financial Results Conference Call for November 12, 2024 at 500 p.m. ET | 10/29/2024 |
6 | Acquisition by Fluet Gregory of 3000 shares of Electromed subject to Rule 16b-3 | 11/04/2024 |
7 | Electromed GAAP EPS of 0.16 beats by 0.13, revenue of 14.67M beats by 1.17M | 11/12/2024 |
8 | Acquisition by James Cunniff of 87500 shares of Electromed subject to Rule 16b-3 | 11/13/2024 |
9 | Disposition of 42453 shares by Kathleen Skarvan of Electromed at 28.1641 subject to Rule 16b-3 | 11/18/2024 |
10 | Disposition of 56945 shares by Kathleen Skarvan of Electromed at 27.9706 subject to Rule 16b-3 | 11/19/2024 |
11 | Electromed director Kathleen Skarvan sells shares worth 4.2 million | 11/20/2024 |
| Begin Period Cash Flow | 7.4 M |
Electromed |
Electromed Relative Risk vs. Return Landscape
If you would invest 1,500 in Electromed on August 28, 2024 and sell it today you would earn a total of 1,526 from holding Electromed or generate 101.73% return on investment over 90 days. Electromed is currently generating 1.1462% in daily expected returns and assumes 2.9994% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Electromed, and 78% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Electromed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Electromed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Electromed, and traders can use it to determine the average amount a Electromed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.3821
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ELMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.0 actual daily | 26 74% of assets are more volatile |
Expected Return
| 1.15 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.38 actual daily | 30 70% of assets perform better |
Based on monthly moving average Electromed is performing at about 30% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Electromed by adding it to a well-diversified portfolio.
Electromed Fundamentals Growth
Electromed Stock prices reflect investors' perceptions of the future prospects and financial health of Electromed, and Electromed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Electromed Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0839 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 238.1 M | ||||
| Shares Outstanding | 8.46 M | ||||
| Price To Earning | 23.66 X | ||||
| Price To Book | 6.07 X | ||||
| Price To Sales | 4.68 X | ||||
| Revenue | 54.72 M | ||||
| Gross Profit | 36.52 M | ||||
| EBITDA | 7.42 M | ||||
| Net Income | 5.15 M | ||||
| Cash And Equivalents | 8.15 M | ||||
| Cash Per Share | 0.96 X | ||||
| Total Debt | 87 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 4.83 X | ||||
| Book Value Per Share | 5.16 X | ||||
| Cash Flow From Operations | 9.07 M | ||||
| Earnings Per Share | 0.72 X | ||||
| Market Capitalization | 255.94 M | ||||
| Total Asset | 52.23 M | ||||
| Retained Earnings | 23.67 M | ||||
| Working Capital | 36.5 M | ||||
| Current Asset | 15.82 M | ||||
| Current Liabilities | 3.07 M | ||||
About Electromed Performance
By analyzing Electromed's fundamental ratios, stakeholders can gain valuable insights into Electromed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Electromed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Electromed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 104.30 | 151.62 | |
| Return On Tangible Assets | 0.10 | 0.10 | |
| Return On Capital Employed | 0.15 | 0.08 | |
| Return On Assets | 0.10 | 0.10 | |
| Return On Equity | 0.12 | 0.06 |
Things to note about Electromed performance evaluation
Checking the ongoing alerts about Electromed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Electromed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 28.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Electromed director Kathleen Skarvan sells shares worth 4.2 million |
- Analyzing Electromed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Electromed's stock is overvalued or undervalued compared to its peers.
- Examining Electromed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Electromed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Electromed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Electromed's stock. These opinions can provide insight into Electromed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |